Cargando…
A chewable low-dose oral contraceptive: a new birth control option?
A new chewable combined oral contraceptive pill containing ethinyl estradiol (EE) 0.025 mg and norethindrone (NE) 0.8 mg in a 24/4 regimen was approved for marketing in December 2010. Each of the four inactive tablets contains 75 mg ferrous fumarate, which has no therapeutic benefit. The tablet can...
Autor principal: | Weisberg, Edith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3346156/ https://www.ncbi.nlm.nih.gov/pubmed/22573934 http://dx.doi.org/10.2147/PPA.S20661 |
Ejemplares similares
-
Formulation of New Chewable Oral Dosage Forms of Meclizine and Pyridoxine Hydrochloride
por: Al-Madhagi, Wafa M., et al.
Publicado: (2023) -
Preparation and evaluation of oral soft chewable jelly containing flurbiprofen
por: Sabri, Lubna Abdalkarim, et al.
Publicado: (2022) -
Bioequivalence of the 4-mg Oral Granules and Chewable Tablet Formulations of Montelukast
por: Knorr, Barbara, et al.
Publicado: (2010) -
Potentially effective therapy of heavy menstrual bleeding with an oestradiol-nomegestrol acetate oral contraceptive: a pilot study
por: Weisberg, Edith, et al.
Publicado: (2017) -
Contraception and endometriosis: challenges, efficacy, and therapeutic importance
por: Weisberg, Edith, et al.
Publicado: (2015)